Carvedilol provides multifaceted cardiovascular protection and hemodynamic benefits through balanced adrenoceptor blockade, antioxidant effects, and modulation of ion channels and metabolism.
Carvedilol offers multifaceted therapeutic potential in cardiovascular diseases through its combined adrenoceptor blockade, antioxidant properties, and ion channel modulation.
Carvedilol is a unique cardiovascular drug of multifaceted therapeutic potential. Its major molecular targets recognized to date are membrane adrenoceptors (beta 1, beta 2, and alpha 1), reactive oxygen species, and ion channels (K+ and Ca2+). Carvedilol provides prominent hemodynamic benefits mainly through a balanced adrenoceptor blockade, which causes a reduction in cardiac work in association with peripheral vasodilation. This drug assures remarkable cardiovascular protection through its antiproliferative/atherogenic, antiischemic, antihypertrophic, and antiarrhythmic actions. These actions are a consequence of its potent antioxidant effects, amelioration of glucose/lipid metabolism, modulation of neurohumoral factors, and modulation of cardiac electrophysiologic properties. The usefulness of carvedilol in the treatment of hypertension, ischemic heart disease, and congestive heart failure is based on a combination of hemodynamic benefits and cardiovascular protection.
Cheng et al. (Fri,) conducted a review in hypertension, ischemic heart disease, and congestive heart failure. Carvedilol was evaluated. Carvedilol provides multifaceted cardiovascular protection and hemodynamic benefits through balanced adrenoceptor blockade, antioxidant effects, and modulation of ion channels and metabolism.